• English
  • Korean
  • Chinese
市場調査レポート - 233823

世界の医薬品産業の分析:市場傾向・マーケティング支出・販売戦略

Global Pharmaceutical Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry

発行 ICD Research
出版日 ページ情報 英文 148 Pages
電子版即納可
価格
世界の医薬品産業の分析:市場傾向・マーケティング支出・販売戦略 Global Pharmaceutical Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry
出版日: 2013年02月19日 ページ情報: 英文 148 Pages
概要

当レポートでは、世界の大手医薬品企業の経営幹部に対する聞き取り調査の結果に基づき、サプライヤー側から見た全世界の医薬品産業の現状・将来動向について分析し、産業全体の事業見通し(産業動向・市場成長予測・市場の機会と脅威に関する見解)や、サプライヤー側の事業展開(各種マーケティング活動・販売戦略など)に関するデータを取りまとめ、それを地域別・企業規模別などで整理して、概略以下の構成でお届けします。

第1章 イントロダクション

  • 当レポートの概要
  • 定義
  • 調査手法
  • 調査回答者のプロファイル
    • バイヤー側の回答
    • サプライヤー側の回答者

第2章 エグゼクティブ・サマリー

第3章 全世界の医薬品産業のダイナミクス

  • 収益成長率予測
    • 企業の種類別回答
    • 地域別回答
    • 総売上高別回答
    • 企業役員の回答
    • 産業間比較
  • 今後の事業構造の発展
    • バイヤー側回答
    • サプライヤー側回答
    • 地域別回答
    • 総売上高別回答
  • 企業合併・買収(M&A)活動の予測
    • バイヤー側回答
    • サプライヤー側回答
    • 地域別回答
    • 総売上高別回答
    • 海外展開/M&A活動の予測
  • 資本支出の予測
    • バイヤー側回答
    • サプライヤー側回答
    • 地域別回答
    • 総売上高別回答
  • 人員採用活動変更の予測
    • バイヤー側回答
    • サプライヤー側回答
    • 地域別回答
    • 総売上高別回答

第4章 市場成長見通し

  • 新興国市場での需要
    • バイヤー側回答
    • サプライヤー側回答
    • 地域別回答
    • 総売上高別回答
  • 先進国市場での需要
    • バイヤー側回答
    • サプライヤー側回答
    • 地域別回答
    • 総売上高別回答

第5章 脅威と機会

  • ビジネス上の主な懸念事項
    • 企業の種類別回答
    • 地域別回答
    • 総売上高別回答
  • バイヤービジネス維持のための主なサプライヤーの活動
    • バイヤー側の反応
    • 地域別回答
    • 総売上高別回答
    • 調達予算別回答
    • 調達決定役員の回答

第6章 サプライヤーのマーケティング支出活動

  • 年間マーケティング予算
    • 地域別回答
    • 総売上高別回答
  • マーケティング支出水準の変更計画
    • 地域別回答
    • 総売上高別回答
    • 支出レベル変更計画と収益期待成長率との関連性
  • 将来投資(メディアチャネル別)
    • 地域別回答
    • 総売上高別回答
  • サプライヤーの将来投資(マーケティング・販売活動向け)
    • 地域別回答
    • 総売上高別回答

第7章 マーケティング・販売活動および戦略

  • マーケティングの主な目標
    • 地域別回答
    • 総売上高別回答
    • 収益期待成長率別回答
  • マーケティング活動の根本的な修正
    • 地域別回答
    • 総売上高別回答
  • 事業見通しのためのニューメディアの活用
    • 地域別回答
    • 総売上高別回答
  • マーケティング代理店選択のための重要な成功要因
    • 地域別回答
    • 総売上高別回答

第8章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Abstract

Product Synopsis

"Global Pharmaceutical Survey 2013-2014: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry" is a new report by ICD Research that analyzes how pharmaceutical industry companies' media spend, marketing and sales strategies and practices, and business planning are set to change in 2013-2014. Additionally, this report also presents comparative analysis between four years of survey results (wherever applicable). This report provides the current size of the marketing and advertising budgets of global pharmaceutical industry suppliers and how spending by global pharmaceutical industry suppliers will change, providing an insight into global marketing behaviour. In addition, the report identifies future growth of global pharmaceutical industry buyers and suppliers and MandA activity. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and sizes."

Introduction and Landscape

Why was the report written?

This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading global pharmaceutical industry executives. The report provides data and analysis on global pharmaceutical industry suppliers' media spend, marketing and sales strategies, and practices and business planning within the global pharmaceutical industry. This report includes key topics such as media channel spending outlooks, media budgets, marketing agency selection criteria, business challenges, and sales tactics of leading suppliers within the global pharmaceutical industry. The report also identifies global pharmaceutical industry buyers' and suppliers' future growth, MandA and investment expectations. Most secondary research reports are based on general industry drivers and do not understand the industry executives' attitude and changing behaviours, creating a gap in presenting the business outlook of the industry. In an effort to bridge this gap, ICD Research created this primary-research based report by gathering the opinions of multiple stake holders in the value-chain of the global pharmaceutical industry

What is the current market landscape and what is changing?

The average size of the annual marketing budget of global pharmaceutical industry supplier respondents stood at US$4.2 million in 2012, a figure that decreased to US$2.6 million in 2013.

What are the key drivers behind recent market changes?

In the process of choosing marketing agencies, the 'ability to target specific audience niches', 'strategic and tactical consulting', and the 'ability to generate leads or setup customer meetings' are considered the most important factors by global pharmaceutical industry suppliers.

What makes this report unique and essential to read?

This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading pharmaceutical industry companies. This report provides the reader with a definitive analysis of the industry outlook and explores how opportunities and demand are set to change in 2013-2014. Additionally, this report also presents comparative analysis between four years of survey results (wherever applicable). Furthermore, the report reveals the current size of pharmaceutical industry suppliers' marketing and advertising budgets and how expenditure by industry suppliers will change, providing insight into global marketing behavior. This report identifies the key marketing aims of organizations and the sales strategies companies will adopt in order to adapt to market conditions in 2013. Additionally, this chapter also aims to identify key amendments to marketing agencies that aid business generation, respondents' criteria for marketing agency selection, and attitudes towards marketing and sales.

Key Features and Benefits

Projects industry trends and revenue growth expectations in 2013.

Drive revenues by understanding future product investment areas and key growth regions.

Uncover key challenges and opportunities and identify key actions required to maintain and win buyer business.

Formulate effective sales and marketing strategies by identifying the overall size of the marketing budgets of global pharmaceutical industry supplier companies.

Identifies the key marketing aims of organizations and which sales strategies companies will be adopting to deal with market conditions in 2013-2014.

Key Market Issues

China, Brazil, and India are the important emerging markets to offer growth in 2013.

'Market uncertainty', 'responding to price pressure', 'rising competition', and 'regulatory changes' are the leading business concerns for the global pharmaceutical industry in 2013.

The average size of the annual marketing budget of global pharmaceutical industry supplier respondents stood at US$4.2 million in 2012, a figure that decreased to US$2.6 million in 2013.

'Social media and networking sites', 'email and newsletters', and 'conferences and events' are expected to have increased expenditure in 2013 as identified by 56%, 48%, and 44% of respondents respectively.

Overall, 'competitor and market intelligence research', 'customer intelligence and analytics', and 'business performance management solutions' were identified as the marketing and sales solutions most expected to be invested in during 2013.

Key Highlights

An analysis of revenue growth expectations by senior level respondents reveals that 62% are 'more optimistic' about their company's revenue growth in 2013.

A significant percentage of pharmaceutical manufacturing industry respondents highlighted that capital expenditure towards 'new product development', 'employee training', and 'IT infrastructure development' would increase in 2013.

The top three priorities for global pharmaceutical industry buyer respondents in 2013 are 'new products and services', 'improve operational efficiency', and 'expand in current markets'.

A total of 49% of respondents from pharmaceutical manufacturing companies, 68% of respondents from CRO and CMO companies, and 64% of respondents from pharmaceutical industry supplier companies anticipate an increase in their current workforce in 2013.

Survey results show that respondents from the global pharmaceutical industry identified the US as offering the highest growth potential among developed countries in 2013-2014.

Table of Contents

1. Introduction

  • 1.1. What is This Report About?
  • 1.2. Definitions
  • 1.3. Methodology
  • 1.4. Profile of Survey Respondents: Global Pharmaceutical Industry
    • 1.4.1. Global pharmaceutical industry: profile of buyer respondents
    • 1.4.2. Global pharmaceutical industry: profile of supplier respondents

2. Executive Summary

3. Global Pharmaceutical Industry Dynamics

  • 3.1. Revenue Growth Projections in the Global Pharmaceutical Industry
    • 3.1.1. Revenue growth projections by company type
    • 3.1.2. Revenue growth projections by region
    • 3.1.3. Revenue growth projections by company turnover
    • 3.1.4. Global pharmaceutical industry: revenue growth expectations by senior level respondents
  • 3.2. Future Developments in Business Structure in the Global Pharmaceutical Industry
    • 3.2.1. Future developments in business structure by buyers
    • 3.2.2. Future developments in business structure by suppliers
    • 3.2.3. Future developments in business structure by region
    • 3.2.4. Future developments in business structure by company turnover
    • 3.2.5. Future developments in business structure by senior level respondents
  • 3.3. Change in Leading Company Strategies in the Global Pharmaceutical Industry
    • 3.3.1. Change in leading company strategies by buyers
    • 3.3.2. Change in leading company strategies by suppliers
    • 3.3.3. Change in leading company strategies by region
    • 3.3.4. Change in leading company strategies by company turnover
  • 3.4. Merger and Acquisition (MandA) Activity Projections in the Global Pharmaceutical Industry
    • 3.4.1. MandA activity projections by buyers
    • 3.4.2. MandA activity projections by suppliers
    • 3.4.3. MandA activity projections by region
    • 3.4.4. MandA activity projections by company turnover
    • 3.4.5. MandA activity projections by purchasing decision authority
    • 3.4.6. Global pharmaceutical industry - expand abroad Vs MandA activity projections
  • 3.5. Estimation of Capital Expenditure in the Global Pharmaceutical Industry
    • 3.5.1. Estimation of capital expenditure by buyers
    • 3.5.2. Estimation of capital expenditure by suppliers
    • 3.5.3. Estimation of capital expenditure by region
    • 3.5.4. Estimation of capital expenditure by company turnover
  • 3.6. Planned Change in Staff Recruitment Activity in the Global Pharmaceutical Industry
    • 3.6.1. Planned change in staff recruitment activity by buyers
    • 3.6.2. Planned change in staff recruitment activity by suppliers
    • 3.6.3. Planned change in staff recruitment activity by region
    • 3.6.4. Planned change in staff recruitment activity by company turnover

4. Global Pharmaceutical Industry Market Growth Outlook

  • 4.1. Global Pharmaceutical Industry: Demand in Emerging Markets
    • 4.1.1. Demand in emerging markets by buyers
    • 4.1.2. Demand in emerging markets by suppliers
    • 4.1.3. Demand in emerging markets by region
    • 4.1.4. Demand in emerging markets by company turnover
  • 4.2. Global Pharmaceutical Industry - Growth Projections in Developed Countries
    • 4.2.1. Growth projections in developed countries by buyers
    • 4.2.2. Growth projections in developed countries by suppliers
    • 4.2.3. Growth projections in developed countries by region
    • 4.2.4. Growth projections in developed countries by company turnover

5. Threats and Opportunities for the Global Pharmaceutical Industry

  • 5.1. Global Pharmaceutical Industry: Leading Business Concerns for 2013-2014
    • 5.1.1. Leading business concerns for 2013-2014 by company type
    • 5.1.2. Leading business concerns for 2013-2014 by region
    • 5.1.3. Leading business concerns for 2013-2014 by company turnover
  • 5.2. Global Pharmaceutical Industry: Key Supplier Actions to Maintain and Win Buyer Business
    • 5.2.1. Actions to maintain and secure buyer business by buyers
    • 5.2.2. Actions to maintain and secure buyer business by region
    • 5.2.3. Actions to maintain and secure buyer business by company turnover
    • 5.2.4. Actions to maintain and secure buyer business by purchasing decision authority

6. Global Pharmaceutical Industry - Supplier Marketing Spend Activity

  • 6.1. Annual Marketing Budgets - Global Pharmaceutical Industry Suppliers
    • 6.1.1. Annual marketing budgets by region - global pharmaceutical industry suppliers
    • 6.1.2. Annual marketing budgets by company turnover - global pharmaceutical industry suppliers
  • 6.2. Planned Change in Marketing Expenditure Levels - Global Pharmaceutical Industry Suppliers
    • 6.2.1. Planned change in marketing expenditure by region - global pharmaceutical industry suppliers
    • 6.2.2. Planned change in marketing expenditure by turnover - global pharmaceutical industry suppliers
    • 6.2.3. Planned change in marketing expenditure by decision making authority - global pharmaceutical industry suppliers
    • 6.2.4. Planned change in marketing expenditure levels vs. revenue growth expectations (%), 2013
  • 6.3. Future Investment by Media Channel - Global Pharmaceutical Industry Suppliers
    • 6.3.1. Future investment by media channel by region - global pharmaceutical industry suppliers
    • 6.3.2. Future investment by media channel by company turnover - global pharmaceutical industry suppliers
  • 6.4. Global Pharmaceutical Industry Suppliers' Future Investment in Marketing and Sales
    • 6.4.1. Planned investment in marketing and sales technologies by region - global pharmaceutical industry suppliers
    • 6.4.2. Planned investment in marketing and sales by turnover: global pharmaceutical industry suppliers

7. Marketing and Sales Behaviors and Strategies in 2013-2014

  • 7.1. Key Marketing Aims for 2013-2014 - Global Pharmaceutical Industry Suppliers
    • 7.1.1. Key marketing aims by region - global pharmaceutical industry suppliers
    • 7.1.2. Key marketing aims by company turnover - global pharmaceutical industry suppliers
  • 7.2. Essential Amendments to Marketing Activities in 2013-2014
    • 7.2.1. Amendments to marketing activities by company turnover - global pharmaceutical industry suppliers
  • 7.3. Critical Success Factors for Choosing a Marketing Agency
    • 7.3.1. Critical success factors for choosing a marketing agency by region
    • 7.3.2. Critical success factors by company turnover - global pharmaceutical industry suppliers

8. Appendix

  • 8.1. Global Pharmaceutical Industry Survey Results- Closed Questions
  • 8.2. Methodology
  • 8.3. Contact us
  • 8.4. About ICD Research
  • 8.5. Disclaimer

List of Tables

  • Table 1: Global Pharmaceutical Industry Survey Respondents by Company Type, 2013
  • Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2013
  • Table 3: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2013
  • Table 4: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2013
  • Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2013
  • Table 6: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2013
  • Table 7: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2013
  • Table 8: Revenue Growth Optimism in the Global Pharmaceutical Industry (%), 2010-2013
  • Table 9: Revenue Growth Optimism in the Global Pharmaceutical Industry by Buyers (%), 2010-2013
  • Table 10: Revenue Growth Optimism in the Global Pharmaceutical Industry by Suppliers (%), 2010-2013
  • Table 11: Revenue Growth Optimism in the Global Pharmaceutical Industry by Region (%),2013
  • Table 12: Revenue Growth Optimism in the Global Pharmaceutical Industry by Turnover (%), 2013
  • Table 13: Revenue Growth Optimism by Senior Level Respondents - Global Pharmaceutical Industry (%), 2013
  • Table 14: Key Expected Changes in Business Structure by Buyers - Global Pharmaceutical Industry (%), 2013
  • Table 15: Key Expected Changes in Business Structure by Suppliers - Global Pharmaceutical Industry (%), 2013
  • Table 16: Key Expected Changes in Business Structure by Turnover - Global Pharmaceutical Industry (%), 2013
  • Table 17: Key Expected Changes In Business Structure by Senior Level Respondents - Global Pharmaceutical Industry (%), 2013
  • Table 18: Change in Leading Company Strategies by Buyers - Global Pharmaceutical Industry (%), 2013
  • Table 19: Change in Leading Company Strategies by Suppliers - Global Pharmaceutical Industry (%), 2013
  • Table 20: Change in Leading Company Strategies by Region - Global Pharmaceutical Industry (%), 2013
  • Table 21: MandA Activity Projections - Global Pharmaceutical Manufacturers' Industry (%), 2010-2013
  • Table 22: MandA Activity Projections - Global CROs and CMOs (%), 2010-2013
  • Table 23: MandA Activity Projections - Global Pharmaceutical Industry Suppliers (%), 2010-2013
  • Table 24: Global Pharmaceutical Industry MandA Activity Projections by Region (%), 2013
  • Table 25: Global Pharmaceutical Industry MandA Activity Projections by Turnover (%), 2013
  • Table 26: Global Pharmaceutical Industry MandA Activity Projections by Purchasing Decision Authority (%), 2013
  • Table 27: Global Pharmaceutical Industry - Expand Abroad vs. MandA Activity Projections(%), 2013
  • Table 28: Change in Capital Expenditure by Global Pharmaceutical Industry Manufacturers(%), 2013
  • Table 29: Change in Capital Expenditure by Global CROs and CMOs (%), 2013
  • Table 30: Change in Capital Expenditure by Pharmaceutical Industry Suppliers (%), 2013
  • Table 31: Global Pharmaceutical Industry - Increase in Capital Expenditure by Region (%), 2013
  • Table 32: Global Pharmaceutical Industry Manufacturers - Planned Change in Staff Recruitment (%), 2013
  • Table 33: Global Pharmaceutical Industry Suppliers - Planned Change in Staff Recruitment Activity (%), 2013
  • Table 34: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Region (%), 2013
  • Table 35: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Turnover (%), 2013
  • Table 36: Global Pharmaceutical Industry Manufacturers - Demand in Emerging Markets (%), 2013
  • Table 37: Global Pharmaceutical Industry CROs and CMOs - Demand in Emerging Markets (%), 2013
  • Table 38: Global Pharmaceutical Industry Suppliers - Demand in Emerging Markets (%), 2013
  • Table 39: Global Pharmaceutical Manufacturers- Growth Projections in Developed Countries (%), 2013
  • Table 40: Global Pharmaceutical CROs and CMOs- Growth Projections in Developed Countries (%), 2013
  • Table 41: Global Pharmaceutical Industry Suppliers - Growth Projections in Developed Countries (%), 2013
  • Table 42: Global Pharmaceutical Industry - Increase in Growth Projections of Developed Countries by Turnover (%), 2013
  • Table 43: Global Pharmaceutical Industry - Leading Business Concerns (%), 2010-2013
  • Table 44: Global Pharmaceutical Industry - Leading Business Concerns by Company Type (%), 2013
  • Table 45: Global Pharmaceutical Industry - Leading Business Concerns by Region (%), 2013-2014
  • Table 46: Global Pharmaceutical Industry - Securing Buyer Business: Buyer vs. Supplier Responses (%), 2013
  • Table 47: Actions to Secure Buyer Business, Global Pharmaceutical Industry Buyer Responses (%), 2013
  • Table 48: Global Pharmaceutical Industry - Securing Buyer Business by Turnover (%), 2013
  • Table 49: Securing Buyer Business in the Global Pharmaceutical Industry - by Purchasing Decision Authority (%), 2013
  • Table 50: Annual Marketing Budgets - Global Pharmaceutical Industry Suppliers (%), 2010-2013
  • Table 51: Annual Marketing Budgets by Region - Global Pharmaceutical Industry Suppliers (%), 2013
  • Table 52: Annual Marketing Budgets by Turnover - Global Pharmaceutical Industry Suppliers (%), 2013
  • Table 53: Planned Change in Marketing Expenditure - Global Pharmaceutical Industry Suppliers (%), 2010-2013
  • Table 54: Planned Change in Marketing Expenditure Levels by Region (%), 2013
  • Table 55: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2013
  • Table 56: Planned Change in Marketing Expenditure Levels by Decision Making Authority (%), 2013
  • Table 57: Change in Marketing Expenditure Levels by Revenue Growth Expectations (%), 2013
  • Table 58: Future Investment by Media Channels - Global Pharmaceutical Industry Suppliers (%), 2013
  • Table 59: Planned Investment in Marketing and Sales Technologies - Global Pharmaceutical Industry Suppliers (%), 2013
  • Table 60: Key Marketing Aims - Global Pharmaceutical Industry Suppliers (%), 2013
  • Table 61: Amendments to Marketing Activities - Global Pharmaceutical Industry Suppliers (%), 2013
  • Table 62: Amendments to Marketing Activities by Company Turnover - Global Pharmaceutical Industry Suppliers (%), 2013
  • Table 63: Critical Success Factors - Global Pharmaceutical Industry Suppliers (%), 2010-2013
  • Table 64: Survey Results - Closed Questions

List of Figures

  • Figure 1: Revenue Growth Optimism in the Global Pharmaceutical Industry (%), 2010-2013
  • Figure 2: Revenue Growth Optimism in the Global Pharmaceutical Industry by Company Type (%), 2010-2013
  • Figure 3: Revenue Growth Optimism in the Global Pharmaceutical Industry by Region (%), 2013
  • Figure 4: Revenue Growth Optimism in the Global Pharmaceutical Industry by Turnover (%), 2013
  • Figure 5: Revenue Growth Optimism by Senior Level Respondents - Global Pharmaceutical Industry (%), 2013
  • Figure 6: Key Expected Changes in Business Structure by Buyers - Global Pharmaceutical Industry (%), 2013
  • Figure 7: Key Expected Changes in Business Structure by Suppliers - Global Pharmaceutical Industry (%), 2013
  • Figure 8: Key Expected Changes in Business Structure by Region - Global Pharmaceutical Industry (%), 2013
  • Figure 9: Change in Leading Company Strategies by Buyers - Global Pharmaceutical Industry (%), 2013
  • Figure 10: Change in Leading Company Strategies by Suppliers - Global Pharmaceutical Industry (%), 2013
  • Figure 11: Change in Leading Company Strategies by Region - Global Pharmaceutical Industry (%), 2013
  • Figure 12: Change in Leading Company Strategies by Turnover - Global Pharmaceutical Industry (%), 2013
  • Figure 13: MandA Activity Projections - Global Pharmaceutical Industry (%), 2013
  • Figure 14: MandA Activity Projections - Global Pharmaceutical Manufacturers' Industry (%), 2010-2013
  • Figure 15: MandA Activity Projections - Global CROs and CMOs (%), 2010-2013
  • Figure 16: MandA Activity Projections - Global Pharmaceutical Industry Suppliers (%), 2010-2013
  • Figure 17: Global Pharmaceutical Industry MandA Activity Projections by Region (%), 2013
  • Figure 18: Global Pharmaceutical Industry MandA Activity Projections by Turnover (%), 2013
  • Figure 19: Global Pharmaceutical Industry MandA Activity Projections by Purchasing Decision Authority (%), 2013
  • Figure 20: Global Pharmaceutical Industry - Expand Abroad Vs MandA Activity Projections (%), 2013
  • Figure 21: Change in Capital Expenditure by Global Pharmaceutical Industry Manufacturers(%), 2013
  • Figure 22: Change in Capital Expenditure by Global CROs and CMOs (%), 2013
  • Figure 23: Change in Capital Expenditure by Pharmaceutical Industry Suppliers (%), 2013
  • Figure 24: Global Pharmaceutical Industry - Increase in Capital Expenditure by Turnover (%), 2013
  • Figure 25: Global Pharmaceutical Industry Manufacturers - Planned Change in Staff Recruitment (%), 2013
  • Figure 26: Global Pharmaceutical Industry Suppliers - Planned Change in Staff Recruitment Activity (%), 2013
  • Figure 27: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Region (%), 2013
  • Figure 28: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Turnover (%), 2013
  • Figure 29: Global Pharmaceutical Industry: Top Ten Growth Regions (%), 2013
  • Figure 30: Global Pharmaceutical Industry: Top Five Emerging Markets, 2013
  • Figure 31: Global Pharmaceutical Industry Manufacturers - Demand in Emerging Markets (%), 2013
  • Figure 32: Global Pharmaceutical Industry CROs and CMOs - Demand in Emerging Markets (%), 2013
  • Figure 33: Global Pharmaceutical Industry Suppliers - Demand in Emerging Markets (%), 2013
  • Figure 34: Global Pharmaceutical Industry - Demand in Emerging Markets by Region (%), 2013
  • Figure 35: Global Pharmaceutical Industry - Demand in Emerging Markets by Turnover (%), 2013
  • Figure 36: Global Pharmaceutical Industry - Top Five Developed Regions by Growth (%), 2013
  • Figure 37: Global Pharmaceutical Manufacturers- Growth Projections in Developed Countries (%), 2013
  • Figure 38: Global Pharmaceutical CROs and CMOs- Growth Projections in Developed Countries (%), 2013
  • Figure 39: Global Pharmaceutical Industry Suppliers - Growth Projections in Developed Countries (%), 2013
  • Figure 40: Global Pharmaceutical Industry - Increase in Growth Projections of Developed Countries by Region (%), 2013
  • Figure 41: Global Pharmaceutical Industry - Top Five Leading Business Concerns, 2013
  • Figure 42: Global Pharmaceutical Industry - Leading Business Concerns (%), 2013
  • Figure 43: Global Pharmaceutical Industry - Leading Business Concerns by Company Type (%), 2013
  • Figure 44: Global Pharmaceutical Industry - Leading Business Concerns by Turnover (%), 2013-2014
  • Figure 45: Global Pharmaceutical Industry - Securing Buyer Business: Buyer vs. Supplier Responses (%), 2013
  • Figure 46: Actions to Secure Buyer Business, Global Pharmaceutical Industry Buyer Responses (%), 2013
  • Figure 47: Global Pharmaceutical Industry - Securing Buyer Business by Region (%), 2013
  • Figure 48: Annual Marketing Budgets - Global Pharmaceutical Industry Suppliers (%), 2010-2013
  • Figure 49: Annual Marketing Budgets by Region - Global Pharmaceutical Industry Suppliers (%), 2013
  • Figure 50: Annual Marketing Budgets by Turnover - Global Pharmaceutical Industry Suppliers (%), 2013
  • Figure 51: Planned Change in Marketing Expenditure - Global Pharmaceutical Industry Suppliers (%), 2010-2013
  • Figure 52: Planned Change in Marketing Expenditure Levels by Region (%), 2013
  • Figure 53: Planned Change in Marketing Expenditure Levels by Decision Making Authority (%), 2013
  • Figure 54: Future Investment by Media Channels - Global Pharmaceutical Industry Suppliers (%), 2013
  • Figure 55: Global Pharmaceutical Industry Suppliers - Investment in Media Channels by Region (%), 2013
  • Figure 56: Global Pharmaceutical Industry Suppliers - Investment in Media Channels by Turnover (%), 2013
  • Figure 57: Planned Investment in Marketing and Sales Technologies - Global Pharmaceutical Industry Suppliers (%), 2013
  • Figure 58: Planned Investment in Marketing and Sales Technologies by Region - Global Pharmaceutical Industry Suppliers (%), 2013
  • Figure 59: Planned Investment in Marketing and Sales Technologies by Company Turnover - Global Pharmaceutical Industry Suppliers (%), 2013
  • Figure 60: Key Marketing Aims - Global Pharmaceutical Industry Suppliers (%), 2013
  • Figure 61: Key Marketing Aims by Region - Global Pharmaceutical Industry Suppliers (%), 2013
  • Figure 62: Key Marketing Aims by Turnover - Global Pharmaceutical Industry Suppliers (%), 2013
  • Figure 63: Amendments to Marketing Activities - Global Pharmaceutical Industry Suppliers (%) , 2013
  • Figure 64: Amendments to Marketing by Turnover - Global Pharmaceutical Industry Suppliers (%) , 2013
  • Figure 65: Critical Success Factors - Global Pharmaceutical Industry Suppliers (%), 2013
  • Figure 66: Critical Success Factors by Region - Global Pharmaceutical Industry Suppliers (%), 2013
  • Figure 67: Critical Success Factors by Turnover - Global Pharmaceutical Industry Suppliers (%), 2013
Back to Top